Disease control in asthmatic children seen in private practice in Switzerland

Current Medical Research and Opinion

Volumn 22, Issue 7, 2006, Pages 1295-1306

  Moeller, Alexander ^a,b   Steurer Stey, Claudia ^a,b   Suter, Herbert ^c   Hofer, Michael ^d   Peter, Manuela ^e   Brooks Wildhaber, Joanne ^a,b   Hammer, Jürg ^a,b   Wildhaber, Johannes H ^a,b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b Alpine Children's Hospital Davos   (Switzerland)

^c Swiss Forum for Practice Paediatrics ^*  (Switzerland)

^d Swiss Society of Paediatrics (SGP)   (Switzerland)

^e Brunner and Hess Software AG   (Switzerland)

Author keywords

Asthma; Asthma control; Asthma therapy; Childhood

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST;

ADOLESCENT; ANXIETY; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; DISEASE CONTROL; DRUG DOSE REGIMEN; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; PEDIATRICIAN; PHYSICAL CAPACITY; PRIVATE PRACTICE; QUESTIONNAIRE; SWITZERLAND; TREATMENT OUTCOME;

ASTHMA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; PRIVATE PRACTICE; QUESTIONNAIRES; SWITZERLAND;

EID: 33746117324     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079906X112633     Document Type: Article

References (70)

1. Braun-Fahrlander C, Gassner M, Grize L, et al. No further increase in asthma, hay fever and atopic sensitisation in adolescents living in Switzerland. Eur Respir J 2004;23:407-13
2. Sennhauser FH, Braun-Fahrlander C, Wildhaber JH. The burden of asthma in children: a European perspective. Paediatr Respir Rev 2005;6:2-7
3. Szucs TD, Anderhub HP, Rutishauser M. Determinants of health care costs and patterns of care of asthmatic patients in Switzerland. Schweiz Med Wochenschr 2000;130:305-13
4. Kuehni CE, Frey U. Age-related differences in perceived asthma control in childhood: guidelines and reality. Eur Respir J 2002;20:880-9
5. Rabe KF, Vermeire PA, Soriano JB, et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000;16:802-7
6. Anon. NAEPP EP, Guidelines for the diagnosis and management of asthma - update on selected topics 2002. Bethesda (MD): National Institutes of Health; 2002
7. Boulet LP, Phillips R, O'Byrne P, et al. Evaluation of asthma control by physicians and patients: comparison with current guidelines. Can Respir J 2002;9:417-23
8. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004;113:59-65
9. Schatz M, Sorkness CA, Li JT, et al. Asthma control test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 2006;117:549-56
10. Landgraf JM, Abetz L, Ware JE. The CHQ user's manual. Boston (MA): The Health Institute, New England Medical Center; 1996
11. Landgraf JM, Abetz LN. Functional status and well-being of children representing three cultural groups: initial selfreports using the CHQ-CF87. Psychol Health 1997;12:839-54
12. Anon. Asthma GGIf, global strategy for asthma management and prevention: NHLBI/WHO workshop report [Publication No 02-3659]. Bethesda (MD): National Institutes of Health, National Heart, Lung and Blood Institute; 2005
13. Halterman JS, McConnochie KM, Conn KM, et al. A potential pitfall in provider assessments of the quality of asthma control. Ambul Pediatr 2003;3:102-5
14. Cabana MD, Bradley J, Meurer JR, et al. Coding for asthma patient education in the primary care setting. J Med Pract Manage 2005;21:115-9
15. Fiese BH, Wamboldt FS, Anbar RD. Family asthma management routines: connections to medical adherence and quality of life. J Pediatr 2005;146:171-6
16. Merikallio VJ, Mustalahti K, Remes ST, et al. Comparison of quality of life between asthmatic and healthy school children. Pediatr Allergy Immunol 2005;16:332-40
17. Williams J, Williams KW. Asthma-specific quality of life questionnaires in children: are they useful and feasible in routine clinical practice? Pediatr Pulmonol 2003;35:114-8
18. Juniper EF, Guyatt GH, Feeny DH, et al. Measuring quality of life in children with asthma. Qual Life Res 1996;5:35-46
19. Juniper EF, Guyatt GH, Feeny DH, et al. Measuring quality of life in the parents of children with asthma. Qual Life Res 1996;5:27-34
20. Annett RD, Bender BG, DuHamel TR, et al. Factors influencing parent reports on quality of life for children with asthma. J Asthma 2003;40:577-87
21. Juniper EF, O'Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14:902-7
22. Sarafino EP, Paterson ME, Murphy EL. Age and the impacts of triggers in childhood asthma. J Asthma 1998;35:213-7
23. Murray CS, Simpson A, Custovic A. Allergens, viruses, and asthma exacerbations. Proc Am Thorac Soc 2004;1:99-104
24. Chipps BE. Determinants of asthma and its clinical course. Ann Allergy Asthma Immunol 2004;93:309-15
25. Sheth KK. Activity-induced asthma. Pediatr Clin North Am 2003;50:697-716
26. Heymann PW, Platts-Mills TA, Johnston SL. Role of viral infections, atopy and antiviral immunity in the etiology of wheezing exacerbations among children and young adults. Pediatr Infect Dis J 2005;24:S217-S222
27. Tan WC. Viruses in asthma exacerbations. Curr Opin Pulm Med 2005;11:21-6
28. Kaufman FL, Kharrazi M, Delorenze GN, et al. Estimation of environmental tobacco smoke exposure during pregnancy using a single question on household smokers versus serum cotinine. J Expo Anal Environ Epidemiol 2002;12:286-95
29. Stordal K, Johannesdottir GB, Bentsen BS, et al. Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease. Arch Dis Child 2005;90:956-60
30. Gold BD. Asthma and gastroesophageal reflux disease in children: exploring the relationship. J Pediatr 2005;146:513-520
31. Gibson PG, Henry RL, Coughlan JL. Gastro-oesophageal reflux treatment for asthma in adults and children. Cochrane Database Syst Rev 2000:CD001496
32. Astarita C, Gargano D, Cutajar M, et al. Gastroesophageal reflux disease and asthma: an intriguing dilemma. Allergy 2000;55(Suppl 61):52-5
33. Field SK. Gastroesophageal reflux and asthma: are they related? J Asthma 1999;36:631-44
34. Schuepp KG, Straub D, Moeller A, et al. Deposition of aerosols in infants and children. J Aerosol Med 2004;17:153-6
35. O'Connell E. Optimizing inhaled corticosteroid therapy in children with chronic asthma. Pediatr Pulmonol 2005;39:74-83
36. Brand PL. Key issues in inhalation therapy in children. Curr Med Res Opin 2005;21(Suppl 4):S27-S32
37. Sly PD, Cahill P, Willet K, et al. Accuracy of mini peak flow meters in indicating changes in lung function in children with asthma. Br Med J 1994;308:572-4
38. Brand PL, Roorda RJ. Usefulness of monitoring lung function in asthma. Arch Dis Child 2003;88:1021-5
39. Brand PL, Duiverman EJ, Postma DS, et al. Peak flow variation in childhood asthma: relationship to symptoms, atopy, airways obstruction and hyperresponsiveness [Dutch CNSLD Study Group]. Eur Respir J 1997;10:1242-7
40. Brand PL, Duiverman EJ, Waalkens HJ, et al. Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long-term treatment with inhaled corticosteroids [Dutch CNSLD Study Group]. Thorax 1999;54:103-7
41. Gern JE, Eggleston PA, Schuberth KC, et al. Peak flow variation in childhood asthma: a three-year analysis. J Allergy Clin Immunol 1994;93:706-16
42. Kamps AW, Roorda RJ, Brand PL. Peak flow diaries in childhood asthma are unreliable. Thorax 2001;56:180-2
43. Yoos HL, Kitzman H, McMullen A, et al. Symptom monitoring in childhood asthma: a randomized clinical trial comparing peak expiratory flow rate with symptom monitoring. Ann Allergy Asthma Immunol 2002;88:283-91
44. Wensley D, Silverman M. Peak flow monitoring for guided self-management in childhood asthma: a randomized controlled trial. Am J Respir Crit Care Med 2004;170:606-12
45. Mortimer KM, Fallot A, Balmes JR, et al. Evaluating the use of a portable spirometer in a study of pediatric asthma. Chest 2003;123:1899-907
46. 1 is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol 2001;107:61-7
47. Male I, Richter H, Seddon P. Children's perception of breathlessness in acute asthma. Arch Dis Child 2000;83:325-9
48. Mitra AD, Ogston S, Crighton A, et al. Lung function and asthma symptoms in children: relationships and response to treatment. Acta Paediatr 2002;91:789-92
49. Wensley DC, Silverman M. The quality of home spirometry in school children with asthma. Thorax 2001;56:183-5
50. Sont JK, Willems LNA, Bel EH, et al. Clinical control and histopathologic outcome of asthma when using airway hyper-responsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med 1999;159:1043-51
51. Zacharasiewicz A, Wilson N, Lex C, et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005;171:1077-82
52. Smith AD, Cowan JO, Brassett KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. New Engl J Med 2005;352:2163-73
53. Pijnenburg MW, Hofhuis W, Hop WC, et al. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax 2005;60:215-8
54. Beck-Ripp J, Griese M, Arenz S, et al. Changes of exhaled nitric oxide during steroid treatment of childhood asthma. Eur Respir J 2002;19:1015-9
55. Pijnenburg MW, Bakker EM, Hop WC, et al. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med 2005;172:831-6
56. Castle W, Fuller R, Hall J, et al. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. Br Med J 1993;306:1034-7
57. Farber HJ, Capra AM, Finkelstein JA, et al. Misunderstanding of asthma controller medications: association with nonadherence. J Asthma 2003;40:17-25
58. Clark NM, Gong M. Management of chronic disease by practitioners and patients: are we teaching the wrong things? Br Med J 2000;320:572-5
59. Meng A, McConnell S. Decision-making in children with asthma and their parents. J Am Acad Nurse Pract 2002;14:363-71
60. Verbeme AA, Frost C, Duiverman EJ, et al. Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. Am J Respir Crit Care Med 1998;158:213-9
61. Vaquerizo MJ, Casan P, Castillo J, et al. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax 2003;58:204-10
62. Simons FE, Villa JR, Lee BW, et al. Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study. J Pediatr 2001;138:694-8
63. Price DB, Hernandez D, Magyar P, et al. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax 2003;58:211-6
64. Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved?: the gaining optimal asthma control study. Am J Respir Crit Care Med 2004;170:836-44
65. Ram FS, Cates CJ, Ducharme FM. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Cochrane Database Syst Rev 2005:CD003137
66. Nelson HS, Weiss ST, Bleecker ER, et al. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006;129:15-26
67. Martinez FD. Safety of long-acting beta-agonists - an urgent need to clear the air. New Engl J Med 2005;353:2637-9
68. Bisgaard H, Szefler S. Long-acting [beta]2 agonists and paediatric asthma. Lancet 367:286-8
69. Currie GP, Lee DKC, Srivastava P. Long-acting bronchodilator or leukotriene modifier as add-on therapy to inhaled corticosteroids in persistent asthma? Chest 2005;128:2954-62
70. SAPP, Pulmonology. Empfehlungen zur Behandlung von obstruktiven Atemwegserkrankungen im Säuglings- und Kindesalter. Paediatrica 2004;15:13-27